Skip to main content
. 2020 Nov 17;14(6):2211–2217. doi: 10.1016/j.dsx.2020.11.012

Table 2.

Challenges in managing individuals with TIDM.

COVID-19 induced Challenges Effects on individuals with T1DM
Use of drugs, such as chloroquine and hydroxychloroquine Higher risk of glycemic fluctuations and hypoglycemia
Effect of ‘lock down’ Lack of physical interaction with peers
Reduced physical activity
Increased screen time
Intake of less healthy food
Psychological stress
Irregular sleep pattern
Increased risk of DKA Fear of contracting COVID-19 in a hospital and delay in seeking medical attention in case of an illness
Difficulties accessing medical supplies
HHS Vulnerability Disclosure